Celerion
Home
Contact
Accessibility
Privacy Policy
Resource Type:
Articles
Preexisting Antibody Assays for Gene Therapy: Considerations on Patient Selection Cutoffs and Companion Diagnostic Requirements
March 13, 2024
The Impact of N-nitrosamine Impurities on Clinical Drug Development
March 17, 2023
Prevalence of Baseline Cardiac Arrhythmias in Participants with Overweight or Obesity in Phase 1 Clinical Trials: Analysis of 24-Hour Holter Electrocardiogram Recordings
February 14, 2023
The Pioneering Tech Speeding Up Drug Development
December 19, 2022
Rifampin Drug-Drug-Interaction Studies; Reflections on The Nitrosamine Impurities Issue
View Article
May 26, 2022
←
Previous Page
1
2
X